The 33-kDa platelet α-granule membrane protein (GMP-33) is an N-terminal proteolytic fragment of thrombospondin

Thrombosis and Haemostasis

Volumn 86, Issue 3, 2001, Pages 887-893

  Damas, C ^a   Vink, T ^a   Nieuwenhuis, H K ^a   Sixma, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Platelet activation; Platelet membrane; Platelet granule; Thrombospondin

Indexed keywords

ALPHA GRANULE MEMBRANE PROTEIN 33; DNA; HEPARIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RUU SP 1 77; PLASMIN; RNA; THROMBOSPONDIN; TRYPSIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DNA CLEAVAGE; FUNCTIONAL ASSESSMENT; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

EID: 0034852782     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616152     Document Type: Article

References (31)

1. Identification of a 33-Kd protein associated with the alpha-granule membrane (GMP-33) that is expressed on the surface of activated platelets
2. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins
3. Antibodies against a 23Kd heparin binding fragment of thrombospondin inhibit platelet aggregation
4. Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery
5. Biochemical characterization of plasma membranes and intracellular membranes isolated from human platelets using Percoll gradients
6. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
7. A protein sequenator
8. Divalent cation-dependent and independent surface expression of thrombospondin on thrombin-stimulated human platelets
9. Characterization of a novel monoclonal antibody (V58A4) raised against a recombinant NH2-terminal heparin-binding fragment of human endothelial cell thrombospondin
10. In vitro establishment and characterization of a human megakaryoblastic cell line
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
12. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
13. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer
14. Revolutions in rapid amplification of cDNA ends: New strategies for polymerase chain reaction cloning of full-length cDNA ends
15. Basic local alignment search tool
16. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin
17. The structure and functional properties of thrombospondin
18. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion
19. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: Modulation of platelet aggregation
20. Thrombospondins
21. Thrombospondin in essential thrombocythemia
22. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1
23. Expression of thrombospondins by endothelial cells - Injury is correlated with TSP-1
24. A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome
25. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
26. Thrombospondin peptides inhibit the secretion-dependent phase of platelet aggregation
27. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins
28. Agglutination of isolated platelet membranes
29. Heparin binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity
30. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin